FDA Meeting for ImmunityBio's Anktiva Drug Scuttled Amid Internal Opposition and Political Pressure

FDA scrapped a meeting about ImmunityBio's Anktiva drug, which was invited to by Republican lawmakers Ron Johnson and Neal Dunn. The meeting was intended to discuss the drug's potential expanded approval. Johnson said FDA officials opposed the lawmakers' attendance, citing concerns about political interference in the review process. An FDA spokesperson said the agency is committed to keeping the drug review process independent and free from outside influence.